Filed regular insolvency proceedings open the door for strategic realignment

Augsburg, 17 November 2025 – German Bionic Systems GmbH (German Bionic), a global leader in the field of AI-supported robotics and smart exoskeleton systems, has filed an application to open insolvency proceedings. Last Friday, the Local Court of Augsburg ordered preliminary insolvency proceedings over the company’s assets and appointed attorney-at-law and restructuring expert Oliver Schartl from the law firm Müller-Heydenreich Bierbach & Kollegen (Augsburg) as preliminary insolvency administrator. Business operations with around 70 employees continue without restriction; an investor process will be launched shortly.

“Despite very positive revenue development and a dynamically growing market, we were confronted with the unexpected withdrawal of investment commitments. The failure of a final financing round triggered a liquidity shortfall that made filing for insolvency unavoidable,” Managing Director Armin G. Schmidt said on Monday. “A structured process is now necessary to secure the company’s ability to act economically and to protect the value that has been created,” he explained. The start-up had expected to reach break-even in summer 2026.

Extensive patent portfolio and established market position

At the core of German Bionic’s corporate value lies cutting-edge technology developed in Germany, based on robotics and applied artificial intelligence, which sets international standards and has been marketed worldwide for many years. Together with a substantial patent portfolio and a highly qualified team at the Augsburg and Berlin locations, the company has a strong technological and personnel foundation that defines its leading position in the global market. In addition to already established products – such as EXIA, an intelligent power suit – this innovative strength opens up significant potential for new application areas.

Preliminary insolvency administrator Oliver Schartl is now working together with the company’s management to stabilize business operations and find a viable, future-oriented solution for German Bionic and its employees. The insolvency has no impact on the global customer base or on systems already deployed in the market.

Investor process to begin shortly

“We will shortly initiate a strategic investor process to find a suitable investor. Given the fact that the product is a technological leader, already established worldwide, and that German Bionic has highly qualified personnel, I see good chances of achieving this already in the first quarter of 2026,” said Schartl. The aim is to preserve German Bionic’s strong international position under a new investor, to continue developing the company over the long term, and to maintain the Augsburg and Berlin locations along with the associated jobs in Germany.

High tech – Made in Germany – that serves people

German Bionic’s solutions are designed around technologies that put people first.. They support workers in physically demanding occupations who are exposed to significant physical strain in their daily work – for example in logistics, construction, skilled trades, or healthcare. The company’s exoskeleton systems provide immediate relief, improve ergonomic conditions, and help protect health and performance over the long term. At the same time, the underlying technology forms the basis for new generations of socially relevant augmentation systems that will become increasingly important in the context of an aging population, rising skilled labor shortages, and growing demand in the health and care sectors. In this way, German Bionic makes an important contribution to making work more human-centered, safer, and more sustainable.

About German Bionic
German Bionic is a European robotics company that develops and manufactures smart exoskeletons and other wearable technologies. As the first company worldwide, German Bionic created a connected exoskeleton for the workplace that uses AI to support lifting movements and prevent incorrect posture. Intelligent power suits such as EXIA protect workers’ health, measurably reduce the risk of accidents and injuries, and thereby improve work processes. For this innovative technology, which puts people back at the center of Industry 5.0, German Bionic has received numerous awards, including the CES “Best of Innovation” Award, Fast Company’s “Innovation by Design” Award, and the European Investment Bank’s “Innovation Champion” Award. German Bionic operates worldwide, with offices in Europe, North America, and Asia.
www.germanbionic.com

Press Contact
Eric Eitel
CCO / Head of Global Communications
Mobile: +49 (0) 175 338 0453
Email: ee@germanbionic.com

About Müller-Heydenreich Bierbach & Kollegen
The German law firm Müller-Heydenreich Bierbach & Kollegen (www.mhbk.de) is a partnership of attorneys that has specialized in restructuring and insolvency administration for many years. A total of seven administrators handle insolvency proceedings at numerous local courts in Bavaria and Thuringia. The firm’s particular strengths include transfer restructuring, insolvency plan proceedings, self-administration, and corporate group insolvencies.
Attorney-at-law and insolvency administrator Oliver Schartl specializes in business continuations and restructurings across a broad range of industries. He is appointed by several courts in Bavaria and has handled more than 1,200 insolvency proceedings to date, including more than 800 corporate insolvency proceedings of all sizes. Schartl is also a member of the Association of Insolvency Administrators and Trustees in Germany (www.vid.de) and of TMA Deutschland e.V. (Turnaround Management Association).

Press Contact
Müller-Heydenreich Bierbach & Kollegen
Nicole Huss
Phone: +49 89 130 12 522
Mobile: +49 172 848 89 28
Email: presse@mhbk.de